Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Marker Therapeutics
MRKR
$19.3M
| $99K | ﹤0.01% |
31,950
+12,600
| +65% | +$21.9K |
|
|
AIOS
3477
AIOS Tech
AIOS
$40.4M
| $99K | ﹤0.01% |
1,338
-273
| -17% | -$24.7K |
|
|
RTB
3478
RTB Digital
RTB
$226M
| $99K | ﹤0.01% |
377
+93
| +33% | +$20.3K |
|
|
YQ
3479
17 Education & Technology Group
YQ
$24.1M
| $99K | ﹤0.01% |
21,411
-1,613
| -7% | -$8.97K |
|
|
ONCT
3480
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $99K | ﹤0.01% |
14,350
+1,595
| +13% | +$10.5K |
|
3481
Lulu's Fashion Lounge
LVLU
$48.5M
| $98K | ﹤0.01% |
2,573
-567
| -18% | -$20.7K |
|
3482
SOPHiA GENETICS
SOPH
$644M
| $97K | ﹤0.01% |
21,600
-2,500
| -10% | -$11.3K |
|
|
CAMP
3483
DELISTED
CalAmp Corp.
CAMP
| $97K | ﹤0.01% |
3,961
+678
| +21% | +$32.9K |
|
|
VRPX
3484
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
| $97K | ﹤0.01% |
357
-24
| -6% | -$4.97K |
|
3485
Eton Pharmaceutcials
ETON
$1.14B
| $96K | ﹤0.01% |
27,600
+14,200
| +106% | +$52.2K |
|
3486
Imunon
IMNN
$6.77M
| $95K | ﹤0.01% |
5,674
+950
| +20% | +$15.7K |
|
3487
QuickLogic
QUIK
$240M
| $95K | ﹤0.01% |
+10,300
| New | +$65.4K |
|
|
ACER
3488
DELISTED
Acer Therapeutics Inc
ACER
| $95K | ﹤0.01% |
102,552
-9,248
| -8% | -$8.2K |
|
3489
Aveanna Healthcare
AVAH
$1.97B
| $94K | ﹤0.01% |
55,400
+4,500
| +9% | +$5.64K |
|
3490
Regis Corp
RGS
$69.3M
| $94K | ﹤0.01% |
4,251
-14,814
| -78% | -$319K |
|
3491
Team
TISI
$101M
| $94K | ﹤0.01% |
11,369
-900
| -7% | -$5.21K |
|
|
BVC
3492
BitVentures Limited Ordinary Shares
BVC
$2.21B
| $94K | ﹤0.01% |
13,600
| – | – |
|
|
ENG
3493
DELISTED
ENGlobal Corp
ENG
| $94K | ﹤0.01% |
31,013
-337
| -1% | -$1.1K |
|
|
SALM
3494
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $93K | ﹤0.01% |
97,200
+2,700
| +3% | +$2.68K |
|
3495
AYTU BioPharma
AYTU
$25.3M
| $92K | ﹤0.01% |
57,323
+7,700
| +16% | +$15.1K |
|
|
IMA
3496
ImageneBio Inc
IMA
$68M
| $92K | ﹤0.01% |
+1,175
| New | +$84.3K |
|
|
AGPU
3497
Axe Compute Inc
AGPU
$92.4M
| $92K | ﹤0.01% |
1,258
+570
| +83% | +$34.6K |
|
|
SYBX
3498
DELISTED
Synlogic
SYBX
| $92K | ﹤0.01% |
14,287
+8,160
| +133% | +$68.2K |
|
|
QXO
3499
QXO Inc
QXO
$16.2B
| $91K | ﹤0.01% |
3,388
-787
| -19% | -$19.9K |
|
|
OMIC
3500
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $91K | ﹤0.01% |
3,657
+2,907
| +388% | +$85.2K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.